Filter by country
Africa
Sao Tome and Principe
Liberia
Madagascar
Malawi
Mali
Mauritania
Mozambique
Niger
Nigeria
Rwanda
Lesotho
Senegal
Sierra Leone
South Sudan
Tanzania, UR
Togo
Uganda
Zambia
Zimbabwe
Cote d'Ivoire
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic (the)
Chad
Comoros (the)
Congo (the)
Angola
Congo, DR
Eritrea
Ethiopia
The Gambia
Ghana
Guinea-Bissau
Guinea
Kenya
South-East Asia
Bangladesh
Bhutan
China
Korea, DPR
India
Indonesia
Myanmar
Nepal
Sri Lanka
Timor Leste
Americas
Cuba
Haiti
Honduras
Nicaragua
Bolivia
Guyana
Europe
Albania
Armenia
Azerbaijan
Bosnia-Herzegovina
Georgia
Kyrgyzstan
Moldova
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Western Pacific
Cambodia
Kiribati
Lao PDR
Mongolia
Papua New Guinea
Solomon Islands
Vietnam
Eastern Mediterranean
Afghanistan
Djibouti
Pakistan
Somalia
Sudan (the)
Yemen
Filter by Category
Documents
Gavi Process Guidelines
IRC reports
Portuguese
Annual Contributions and Proceeds
Cash Receipts
Advocacy
Resource mobilisation
German
COVID-19 situation report
COVAX documents
COVAX AMC
Russian
Gavi Programme Funding Guidelines
Programme audit
Internal audit
Investigation
Reports to the Board
Other (IA)
COVAX data brief
DHI
VIS
White papers
AMC Documents
Country Documents
Evaluations
Financial Reports
Guidelines and Forms
Legal
Strategy
Supply and Procurement
Policies
Annual Reports
Gavi Fact Sheets
Gavi Publications
The Evidence Base
Gavi Bulletin
Other Publishers
Board Minutes
Committee minutes
Audit
Spanish
News
AMC Updates
Gavi Features
Press Releases
Roi
Statements
Gavi Blogs
Vaccineswork
Theme - Pentavalent
Top stories
3rd donor pledging
3rd donor pledging featured
Partner news
IATI
Social media toolkit
Audio Visual
Infographics
Presentations
Videos
Galleries
Board
Committee
Members

Articles (4215)

Showing 12 of 4215 View All
Showing 215 of 352 pages

500,000 doses of Ebola vaccine to be made available to countries for outbreak response

A Gavi-funded global emergency stockpile of Ebola vaccines will be accessible to all countries following a procurement process concluded by UNICEF

COVID-19 immunity: how long does it last?

Long-term protection will depend on the 'memory response' developed by our immune systems – and the initial signs are promising.

From biodefence to the DRC: How the Ebola vaccine became one of the fastest vaccines to license in history

COVID-19 vaccines are set to become the quickest vaccines in history to go from initial trials to rollout, but what lessons can we learn from its speedy predecessor: the Ebola vaccine?

Lessons from Rwanda’s Fight Against COVID-19

While some of the world's richest and most technologically advanced countries have struggled to contain the spread and morbidity of COVID-19, Rwanda has set a shining example of how to manage a pandemic and safeguard public health. Chief among…

Why delivering COVID-19 vaccines might be just as hard as developing them

From Liability Laws to Production Delays, the 2009 H1N1 Swine Flu Vaccine Rollout Offers a Cautionary Tale for Today.

Coronavirus: few vaccines prevent infection – here’s why that’s not a problem

Sterilising immunity means that the immune system is able to completely prevent a virus from replicating in your body. Not all vaccines provide this.

Trekking through the snow to deliver vaccines

Vaccinators tackle winter conditions and challenging contexts during Afghanistan’s last polio campaign of the year.

COVID-19 comes as a double blow to those living with HIV

In March 2020, as soon as the first cases of COVID-19 were detected in Kyrgyzstan, a state of emergency was declared, and the country went into lockdown.

Can Poor Countries Avoid a Vaccine Bidding War?

For all of the good news about the arrival of safe and effective COVID-19 vaccines, the hard truth for the coming year is that global demand will outpace supply. Without a multilateral agreement to allocate doses globally, the road to recovery…

Is altering the dosing strategy of COVID-19 vaccines a good idea?

Uncertainty in the availability of vaccine doses is prompting some countries to consider altering dosing schedules, or mixing different vaccine types. How could this impact the effectiveness of vaccines?

COVID-19 FAQs: The 10 questions you need to know the answer to

We believe the best way to address misconceptions is to arm yourself with the facts and have a few key points and statistics. Here’s our list of facts to combat common misinformation.

Coronavirus vaccines: how will we know when life can go back to normal?

Here's what we still need to find out before we can know when we'll be able to return to our pre-coronavirus ways.

Subscribe to our newsletter